InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ODN | Ann: Market Update | 28/03/19 | 17 | 2.4K | |||
|
|||||||
ODN | News: ODN Odin Energy Confirms No Current Plans To Raise Further Capital For Gridcomm | 19/03/19 | 0 | 166 | |||
|
|||||||
ODN | Ann: Market Update | 14/03/19 | 41 | 11K | |||
|
|||||||
ODN | GridComm Facebook page is ALIVE!! | 15/02/19 | 1 | 641 | |||
|
|||||||
ODN | Ann: Financial Report 31 Dec 2017 | 10/01/19 | 30 | 6.2K | |||
|
|||||||
ODN | Ann: Correction to Related Party Note in Annual report | 11/12/18 | 4 | 1.1K | |||
|
|||||||
ODN | Ann: Interim Financial report Half year 30 June 2017 | 28/11/18 | 0 | 197 | |||
|
|||||||
ODN | Ann: Financial report year ended 31 Dec 2016 | 28/11/18 | 0 | 168 | |||
|
See All Discussions